Immunogenomics were used to identify tumor-specific neoantigens in two well characterized models of glioblastoma. Endogenous immune responses harbored neoantigen-specific T cells within the brain and lymph nodes, providing a tractable system for additional preclinical immunotherapeutic studies in these systems. 
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Survival of Lung Adenocarcinoma Patients Predicted from Expression of PD-L1, Galectin-9, and XAGE1 (GAGED2a) on Tumor Cells and Tumor-Infiltrating T Cells Yoshihiro Ohue, Koji Kurose, Ryohei Nozawa, Midori Isobe, Yumi Nishio, Tomonori Tanaka, Yoshinori Doki, Takashi Hori, Junya Fukuoka, Mikio Oka, and Eiichi Nakayama The survival of lung adenocarcinoma patients could be predicted with the use of a discriminant function using as parameters tumor cell expression of PD-L1, Galectin-9, and XAGE1 (GAGED2a), and CD4 and CD8 T-cell infiltration. 
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The tumor microenvironment is an inhospitable locale for T cells, particularly those that are activated and presumed functional. One of the recently recognized harsh conditions is that the tumor cells (red), having ramped up their metabolism, have extreme needs for glucose and other nutrients. Activated T cells (faded blue), having done a similar switch to their own metabolism, also have much higher energy requirements. Thus, activated T cells that migrate into tumors find themselves in a nutrient desert (tan area) and, being starved, alter their phenotype to require much less energy, becoming less functional with an "exhausted" phenotype. To request permission to re-use all or part of this article, contact the AACR Publications Department at
